Vancomycin-resistant enterococci risk factors
|
Vancomycin-resistant enterococci Microchapters |
|
Differentiating Vancomycin-Resistant Enterococci from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Vancomycin-resistant enterococci risk factors On the Web |
|
American Roentgen Ray Society Images of Vancomycin-resistant enterococci risk factors |
|
Directions to Hospitals Treating Vancomycin-resistant enterococci |
|
Risk calculators and risk factors for Vancomycin-resistant enterococci risk factors |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Prior treatment with antibiotics is common in nearly all patients colonized or infected with MDR enterococci. Clindamycin, cephalosporin,aztreonam, ciprofloxacin, aminoglycoside, and metronidazole use is equally or more often associated with colonization or infection with MDR enterococci than vancomycin use. Other risk factors include prolonged hospitalization; high severity of illness score; intraabdominal surgery; renal insufficiency; enteral tube feedings; and exposure to specific hospital units, nurses, or contaminated objects and surfaces within patient-care areas.